Volitionrx (VNRX) EBIT Growth (1y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | 16.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.66% |
| Sep 30, 2025 | 13.08% |
| Jun 30, 2025 | 9.91% |
| Mar 31, 2025 | 34.14% |
| Dec 31, 2024 | 33.86% |
| Sep 30, 2024 | 32.18% |
| Jun 30, 2024 | 26.79% |
| Mar 31, 2024 | 7.30% |
| Dec 31, 2023 | -9.11% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | -17.90% |
| Mar 31, 2023 | -17.82% |
| Dec 31, 2022 | 8.81% |
| Sep 30, 2022 | -5.69% |
| Jun 30, 2022 | -37.26% |
| Mar 31, 2022 | -26.16% |
| Dec 31, 2021 | -55.24% |
| Sep 30, 2021 | -67.89% |
| Jun 30, 2021 | -13.20% |
| Mar 31, 2021 | -3.63% |
| Dec 31, 2020 | -51.92% |
| Sep 30, 2020 | -7.86% |
| Jun 30, 2020 | -26.39% |
| Mar 31, 2020 | -47.23% |
| Dec 31, 2019 | 12.46% |
| Sep 30, 2019 | 6.10% |
| Jun 30, 2019 | 9.67% |
| Jun 30, 2013 | -12.46% |
| Mar 31, 2013 | -13.23% |